Jump to content

Park Seung-cheol

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Trappist the monk (talk | contribs) at 14:04, 15 November 2019 (Death: cite repair;). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Template:Korean name

Park Seung-cheol
Born(1940-01-05)5 January 1940
Died1 June 2014(2014-06-01) (aged 74)
NationalitySouth Korean
Alma mater
OccupationPhysician
Korean name
Hangul
박승철
Hanja
朴陞哲[1]
Revised RomanizationBak Seung-cheol
McCune–ReischauerPak Sŭngchŏl

Park Seung-cheol (5 January 1940 – 1 June 2014) was a South Korean physician and specialist in infectious diseases.

Early life

Park was the first son of Korean independence activist and Provisional Government of the Republic of Korea official Park Myeong-ryeol,[2] who lived in exile in China during Japanese colonial rule.[3] After World War II, the family returned to Korea, where the young Park was raised. When the Korean War broke out, he fled with his family to his father's hometown of Gwangcheon-eup, in Hongseong-gun, Chungcheongnam-do near the city of Gongju.[citation needed] He attended Gwangcheon Elementary School before returning to Seoul, where he studied at Kyungbock High School.[4] He graduated from Seoul National University's Department of Medicine in 1965 and went on to earn Masters and Ph.D. degrees in internal medicine from the same university.[5]

Career

Park became an associate professor at Hanyang University, before moving to Korea University.[5] During the 2002–2004 severe acute respiratory syndrome (SARS) outbreak he served as chairman of the South Korean government's SARS Response Advisory Committee.[6][7] In 2003 he was awarded the Order of Service Merit by President Roh Moo-hyun for his role in fighting SARS.[8] From 2004 to 2006 he was the CEO of the Central Veterans' Hospital (중앙보훈병원) in Seoul.[5] In 2006 he became the founding director of the Korean Society for Zoonoses, and an emeritus fellow of the Korean Academy of Science and Technology.[4] In 2008 he began working as a consultant to the Samsung Medical Center.[5] During the 2009 flu pandemic, he also served as chairman of the South Korean government's New Flu Advisory Committee.[9]

Death

He died on the morning of 1 June 2014 at the Samsung Seoul Hospital.[10][11]


References

  1. ^ 漢陽의대 高應麟·朴陞哲박사 서울近郊山岳水質조사 [Hanyang Medical School professors Go Eung-rin and Park Seung-cheol's research on water quality in mountains near Seoul]. Kyunghyang Shinmun. 16 November 1976. Retrieved 26 May 2016.
  2. ^ 공훈록보기. 「대전현충원묘적부」「독립유공자공훈록」. Vol. 11. Daejeon National Cemetery. 9 May 2016. pp. 116–117. Retrieved 27 May 2016.
  3. ^ 송병기 [Song Byeong-gi] (7 June 2004). '온종일 환자 북적북적 이젠 병실이 모자라요': 박승철 서울보훈병원장 ['All day long, crowds of patients and not enough rooms': Seoul Veterans' Hospital director Park Seung-cheol]. Medical Observer. Retrieved 26 May 2015.
  4. ^ a b 이상기 [Yi Sang-gi] (2 June 2014). (삶과 추억) '영원한 의사' 박승철 SARS대책위원장님 영전에. The Asian/Next News Network. Archived from the original on 12 May 2015. Retrieved 26 May 2016.
  5. ^ a b c d '사스' (SARS) 용어의 창시자 전염병 명의, 박승철 교수 [Professor Park Seung-cheol, the famous doctor who came up with the term 'SARS']. Chosun Ilbo. 15 May 2012. Retrieved 26 May 2016.
  6. ^ 안종주 [Ahn Jong-ju] (30 April 2004). 박승철 사스대책 자문위원장 '독감보다 훨씬 덜 위험' [Park Seung-cheol, chairman of SARS response advisory committee: 'much less dangerous than influenza']. Hankyoreh. Retrieved 26 May 2016.
  7. ^ 양상훈 [Yang Sang-hun] (18 June 2015). '병균에도 이기고 '두려움'균에도 이기자'. Chosun Ilbo.
  8. ^ 김승련 [Kim Seung-ryeon] (2 July 2003). 사스대책 유공자 6명에 훈포장 [Six contributors to SARS response receive decorations]. Dong-A Ilbo. Retrieved 26 May 2016.
  9. ^ 박승철 (3 May 2009). '신종(新種)독감'은 이미 '신종(新種)'이 아니다 ['New flu' isn't 'new' yet]. Chosun Ilbo.
  10. ^ 부음: 박승철씨 별세 외 [Death notice: passing of Park Seung-cheol]. Segye Ilbo. 1 June 2014. Retrieved 25 May 2016.
  11. ^ 엄중식 [Eom Jung-sik] (18 June 2014). 故 박승철 선생님을 보내드리며 [Remembering the late Dr. Park Seung-cheol]. Doctor's News. Retrieved 26 May 2016.